HCWB (HCW Biologics Inc.) Stock Market Reviews

crown

search

Read and share opinions on HCWB (HCW Biologics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

HCWB

HCW Biologics Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results
Nov 14, 2025
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
Nov 10, 2025
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Nov 7, 2025
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
Oct 22, 2025
HCW Biologics to Participate in the 2025 Maxim Growth Summit
Oct 16, 2025
HCW Biologics’ Scientists to Present Three Posters During the 40th Annual Meeting of the Society for Immunotherapy of Cancer
Oct 16, 2025
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program
Sep 30, 2025
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
Sep 18, 2025
HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market
Aug 25, 2025
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
Aug 18, 2025
HCW Biologics Second Quarter 2025 Earnings: US$0.90 loss per share (vs US$16.16 loss in 2Q 2024)
Aug 16, 2025
Insiders Re-Evaluate Their US$3.05m Stock Purchase As HCW Biologics Falls To US$6.9m
Jul 2, 2025
HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors
Jun 27, 2025
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements
Jun 26, 2025
HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech
Jun 4, 2025

Reviews